Concepedia

Emily A. Hull-Ryde

EA

Statistics

Publications

21

Citations

2.2K

H-Index

16

Active since

1983

Affiliations

University of North Carolina at Chapel Hill(Current)

Research Triangle Park Foundation

Lung Institute

Southern Research Institute

American Heart Association

Emily A. Hull-Ryde is an author at University of North Carolina at Chapel Hill specializing in pharmacology, life sciences, and ligand binding.

Publications per year

1983–2021

21

Publications

21

Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662

Lisa M. Leesnitzer, Derek J. Parks, Randy K. Bledsoe et al. · Biochemistry · 2002 · 561 citations

, , +17

A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation

Jennifer L. Oberfield, Jon L. Collins, Christopher P. Holmes et al. · Proceedings of the National Academy of Sciences · 1999 · 318 citations

, , +16

<i>N</i>-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents

Brad R. Henke, Steven G. Blanchard, Marcus F. Brackeen et al. · Journal of Medicinal Chemistry · 1998 · 301 citations · Full text

, , +10

AMP Is an Adenosine A1 Receptor Agonist

Joseph E. Rittiner, Ilia Korboukh, Emily A. Hull-Ryde et al. · Journal of Biological Chemistry · 2012 · 128 citations · Full text

, , +14

<i>N</i>-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 3. Structure−Activity Relationship and Optimization of the <i>N</i>-Aryl Substituent

Jeff E. Cobb, Steven G. Blanchard, Evan G. Boswell et al. · Journal of Medicinal Chemistry · 1998 · 111 citations · Full text

, , +14

1–5 of 21